Navigation Links
arGEN-X raises EUR 5 Million from PMV in Extension of EUR 32.5 Million Series B
Date:11/4/2013

BREDA, The Netherlands and GHENT, Belgium, November 4, 2013 /PRNewswire/ --

Funds to advance ARGX-113, a novel antibody fragment approach to promote degradation and clearance of disease-causing autoantibodies, towards clinical development

arGEN-X, a clinical stage human therapeutic antibody company, has raised EUR 5 million ($6.8 million) as an extension of its series B financing round from the Flemish investment company PMV as a new investor. arGEN-X' series B round, which had its first close in December 2011, now totals EUR 32.5 million ($44 million).

The proceeds will be used to accelerate the Company's ARGX-113 preclinical program towards clinical development. ARGX-113 is a novel therapeutic approach to virtually any antibody-mediated pathology. ARGX-113 exploits arGEN-X' proprietary ABDEG™ technology which clears and degrades systemic disease-causing autoantibodies. ARGX-113 is applicable to most autoimmune diseases (e.g. rheumatoid arthritis, systemic lupus erythmatosus), including unmet orphan indications (e.g. myasthenia gravis, immune thrombocytopenic purpura, Kawasaki disease). ARGX-113 has also a potential use in other therapies where anti-drug antibodies eventually reduce or neutralize the effect of therapeutic proteins.

PMV is an independent investment company that invests in companies contributing to sustainable economic development in the region of Flanders. PMV has a EUR 900m portfolio of assets under management. Life sciences represent a particular focus area for PMV's corporate investments. At arGEN-X, PMV joins a blue-chip group of international investors including OrbiMed Advisors, Seventure Partners, Forbion Capital Partners, Omnes Capital, LSP, BioGeneration Ventures, the Erasmus Biomedical Fund, Thuja Capital and VIB.

Tim Van Hauwermeiren, CEO of arGEN-X, commented: "The ARGX-113 program has made rapid and exciting progress
'/>"/>

SOURCE arGEN-X
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. arGEN-X Appoints Dr. David L. Lacey to its Supervisory Board
2. arGEN-X Announces Preclinical Development of ARGX-112 for Dermatology
3. arGEN-X Identifies Potent Antibody Antagonists against Complex Chronic Pain Target Nav1.7
4. arGEN-X Initiates Phase IbStudy of ARGX-111 in Cancer
5. Evergreen Healthcare Foundation Gala Raises Nearly $1.1 Million to Benefit Breast Health Center
6. Xtelligent Media Raises $800K in Funding and Launches EHRintelligence.com
7. National Patient Advocate Foundation Praises Signing of the Delaware Cancer Treatment Access Act into Law
8. BHI Raises Awareness of Hearing Aids as Potential Therapy to Help Quiet "Ringing in the Ears" During National Tinnitus Awareness Week
9. Perrigo Reports Record Third Quarter Revenue And Earnings And Raises Full Year EPS Guidance
10. Auxilium Pharmaceuticals, Inc. Raises Revenue Guidance And Reduces Net Loss Guidance For 2012
11. Halo Therapeutics Raises $1.1 Million to Expedite Phase 2 Study of HT-100
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2015)... Aug. 27, 2015 WuXi PharmaTech (Cayman) Inc. ... technology platform company serving the pharmaceutical, biotechnology, ... process development and manufacturing subsidiary Shanghai SynTheAll ... approval from the Japan PMDA for the ... branded commercial drug in July. STA is ...
(Date:8/27/2015)... CAMBRIDGE, Mass. , Aug. 27, 2015 Oryzon ... & Renshaw 17th Annual Global Investment Conference in ... Hotel, ORYZON will be represented by President and CEO ... Dr. Buesa will present this information on Thursday September ... (2nd Floor).  The company is completing preclinical development of its ...
(Date:8/26/2015)... NEW YORK , Aug. 26, 2015 The ... a CAGR of 7.0% between 2014 and 2019. Although ... Computerized Physician Order Entry market, India ... the forecast period in this regional market. The increasing demand ... government bodies for implementation of these systems in healthcare facilities ...
Breaking Medicine Technology:WuXi PharmaTech's STA Subsidiary Receives First Approval from Japanese Regulatory Authorities 2ORYZON to Present at Rodman & Renshaw 17th Annual Global Investment Conference 2ORYZON to Present at Rodman & Renshaw 17th Annual Global Investment Conference 3ORYZON to Present at Rodman & Renshaw 17th Annual Global Investment Conference 4Asian Computerized Physician Order Entry Market by Product, by Deployment, by Component -Forecast to 2019 2Asian Computerized Physician Order Entry Market by Product, by Deployment, by Component -Forecast to 2019 3
... vitro microbiology and proof of concept in topical ... March 2007 - Arpida Ltd.,(SWX: ARPN) today announced ... against a large panel of,clinical isolates, including those ... of AR-2474 were found,to be highly effective in ...
... Autism Association calls 2006 Pediatrics study fatally,flawed, CHICAGO, ... at a National Autism Association meeting,bolster claims that ... of,autism spectrum disorders. David Ayoub, MD presented data,suggesting ... pervasive developmental disorder (PDD), a form of autism,in ...
Cached Medicine Technology:Arpida adds novel antibiotic AR-2474 to its preclinical pipeline 2Arpida adds novel antibiotic AR-2474 to its preclinical pipeline 3Newly Released Canadian Data Links Vaccines with Pervasive,Developmental Disorder 2
(Date:8/27/2015)... ... August 27, 2015 , ... More destinations and stores are becoming pet-friendly, ... Amica Insurance is sharing some tips to help your whole family travel safely and ... travel with pets each year. Amica is sharing the following tips from the American ...
(Date:8/27/2015)... ... August 27, 2015 , ... ... for quality market research promotion on the Internet. MarketPublishers.com is now authorised ... Commenting on the partnership agreement, Natalie Aster, Assistant Manager at Partners Department, ...
(Date:8/27/2015)... , ... August 27, 2015 , ... ... Hope and Innovation has grown to having twelve offices in three counties, LA, ... hospitals in the Southern California region. Founded by Dr. Richy Agajanian, the ...
(Date:8/27/2015)... ... August 27, 2015 , ... ... firm that helps libraries, publishers and companies leverage key operational, technical, business ... the VIVO Project. Gunter Media Group, Inc., will provide VIVO related services ...
(Date:8/27/2015)... ... ... An inventor from Gibertsville, Pa., knows how knees can get in the way ... trying to sleep," he said, "so I decided that there needs to be a ... KNEE GUARD helps a user get a better sleep by preventing the knees from ...
Breaking Medicine News(10 mins):Health News:Amica Unleashes 5 Tips for Safe Traveling with Pets 2Health News:Market Publishers Ltd and Black Swan Analysis Sign Partnership Agreement 2Health News:Market Publishers Ltd and Black Swan Analysis Sign Partnership Agreement 3Health News:California’s Largest Private Oncology Practice Serves 50,000 Patients in 8 years 2Health News:DuraSpace Selects Gunter Media Group, Inc. as a Registered Service Provider for VIVO 2Health News:DuraSpace Selects Gunter Media Group, Inc. as a Registered Service Provider for VIVO 3
... University Medical School in Durham, North Carolina and colleagues have ... pain. Patients who use religion or spirituality to cope with ... and boost their sense of well being, the researchers say. ... with chronic illness or chronic pain might find it difficult ...
... liver can injure the donor, it is now established without doubt ... to a person needing it. And the good news is that ... part of his/her liver. ,Donation of a piece of the ... new procedure. It is increasingly being performed in the West where ...
... research-cum-manufacturing agreement between Chiron Corp, the US-based vaccine major, ... potential AIDS vaccine to halt the spread of the ... stage of finalisation. ,Two Hyderabad-based biotechnology/pharma companies -- ... front-runners for the proposed project, which entails an upfront ...
... of the American Association of Endodontists in New Orleans, Louisiana, ... terse message, the dentists said that all toothache need not ... because it may be the early warning for more important ... hygiene has never received its due importance from the masses. ...
... the British government says that smoking will turn out to ... the threat of even HIV. The British broadcasting corporation reported ... more people than any other disease in the next 20 ... in Sussex, United Kingdom, says smoking and other tobacco related ...
... up to 3 million lives a year. WHO released a ... March. The report says most of those who die are ... the developing world are particularly at risk for water-borne diseases. ... contaminated water and 90% of those deaths are among children ...
Cached Medicine News:Health News:Development of AIDS vaccine -- Chiron Corp in talks with four Indian cos 2
... and Cronin, Inc. is ... Patient Footwear, Orthopedic Softgoods, ... Products. Our products are ... and available in the ...
... and Cronin, Inc. is ... Patient Footwear, Orthopedic Softgoods, ... Products. Our products are ... and available in the ...
... The Blue Line UNO Splint fits small, medium, ... cushioned two-part design includes both dorsal and volar ... extension. Recommended for those experiencing symptoms of Carpal ... for busy clinics - stock one splint to ...
Comfort Wrist Immobilizer with thumb abduction. 8"L, soft, padded comfort-type wrist immobilizer with dorsal metal stay. The thumb is held in abduction and splintered with a short metal stay....
Medicine Products: